Jakubowicz et al. found a 28% reduction in postprandial glycemic levels and increased responses in insulin, C-peptide, GLP-1, and GIP secretions when a whey preload was administered before a high glycemic index breakfast to a group of well-controlled type 2 diabetic patients [68]. The gene discussed is INS; the disease is type 2 diabetes mellitus.